Ocera Therapeutics Reports Second Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Ocera Therapeutics (OCRX) Misses Q2 EPS by 6c
August 3, 2015 4:14 PM EDTOcera Therapeutics (NASDAQ: OCRX) reported Q2 EPS of ($0.46), $0.06 worse than the analyst estimate of ($0.40).
For earnings history and earnings-related data on Ocera Therapeutics (OCRX) click here.
... More